Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease
about
The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosisOral progestagens before menopause and breast cancer risk.Activated protein C resistance among postmenopausal women using transdermal estrogens: importance of progestogen.Dydrogesterone and other progestins in benign breast disease: an overview.
P2860
Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Progestogen use and decreased ...... men with benign breast disease
@ast
Progestogen use and decreased ...... men with benign breast disease
@en
Progestogen use and decreased ...... men with benign breast disease
@nl
type
label
Progestogen use and decreased ...... men with benign breast disease
@ast
Progestogen use and decreased ...... men with benign breast disease
@en
Progestogen use and decreased ...... men with benign breast disease
@nl
prefLabel
Progestogen use and decreased ...... men with benign breast disease
@ast
Progestogen use and decreased ...... men with benign breast disease
@en
Progestogen use and decreased ...... men with benign breast disease
@nl
P2093
P2860
P356
P1476
Progestogen use and decreased ...... men with benign breast disease
@en
P2093
Mauvais-Jarvis P
Plu-Bureau G
Sitruk-Ware R
Thalabard JC
P2860
P2888
P304
P356
10.1038/BJC.1994.291
P407
P577
1994-08-01T00:00:00Z
P5875
P6179
1002650602